New board game from Eric Lang goes full-on gangsta.
NYS Entity Status
- Dissolution (Mar 03, 2005)
NYS Filing Date
DECEMBER 19, 2003
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2003 - CORLEONE & HORAN, LLC
Around the Web
- A board game you can’t refuse? The Godfather: Corleone’s Empire
By Ars Staff - Saturday Jul 8, 2017
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Tracee Ellis Ross to host the American Music Awards
Tuesday Nov 14, 2017
NEW YORK (AP) — Tracee Ellis Ross will be close by when her mom, Diana Ross, is honored at Sunday's American Music Awards because she'll be hosting the show.The "black-ish" actress says she's excited to be named the host but is "especially thrilled" to do it the year that her mother is getting the Lifetime Achievement award.Diana Ross will not only be honored but will also take the stage to perform. Tracee Ellis Ross is following in the footsteps of her mom, who hosted the American Music Awards years ago.Performers at Sunday's event in Los Angeles include Kelly Clarkson, Selena Gomez, Demi Lovato and Niall Horan.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]